CD38 antigen as a marker for immunological follow-up in HIV-positive patients;Antigen CD38 jako ukazatel pro imunologické sledová ní HIV-pozitivních osob

Klinicka Mikrobiologie a Infekcni Lekarstvi

Volumn 10, Issue 5, 2004, Pages 229-235

  Holub, Michal ^a,b   Beran, O ^a,c   Kalanin, J ^b,d   Hnykova J ^a   Spala J ^a,b   Rozsypal, H ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^c WADSWORTH CENTER   (United States)

^d Oddeleni Klinicke Imunologie   (Czech Republic)

Author keywords

CD38; CD4+ T lymphocytes; CD8+ T lymphocytes; HAART; HIV AIDS

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD8 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMETRY; DIAGNOSTIC VALUE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANALYSIS; FOLLOW UP; GENE EXPRESSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PROGNOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; VIROLOGY;

ADP-RIBOSYL CYCLASE; ADULT; ANTIGENS, CD; ANTIGENS, CD38; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED;

EID: 9244254316     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Pantaleo G, Fauci AS. Immunopathogenesis of HIV infection. Annu Rev Microbiol 1996;50:825-54.
2. Bentwich Z, Kalinkovich A, Weisman Z, et al. Immune activation in the context of HIV infection. Clin Exp Immunol 1998;111:1-2.
3. Sousa AE, Carneiro J, Meier-Schellersheim M, et al. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to viral load. J Immunol 2002;169:3400-6.
4. + T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-16.
5. Tortajada C, Garcia F, Plana M, et al. Comparison of T-cell subsets reconstitution after 12 months of highly active antiretroviral therapy initiated during early versus advanced states of HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 2000;25:296-305.
6. + T cells in human immunodeficiency syndrome virus 1-positive adults treated with HAART. Acta Virol 2003;47:121-24.
7. + T cells as a marker of poor prognosis in HIV infection: results of 6 years follow-up. Cytometry 1996;26:1-7.
8. + T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes lowards normalization under treatment. The Swiss HIV cohort study. Clin Exp Immunol 1999;115:458-63.
9. Savarino A, Bottarel F, Malavasi F, et al. Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interaction? AIDS 2000;14:1079-89.
10. Barlett JG. Antiretroviral treatment. In: Gorbach SL, Barlett JG, Blacklow NR, eds: Infectious diseases, 3rd edn. Philadelphia, LippincottWilliams & Wilkins, 2004:1028-38.
11. Veselý R, Barths J, Vanlangendonck F, et al. Initial results of Central European Immunophenotyping Quality Control Program (CEQUAL). Cytometry 1996; 26:108-12.
12. Palella FJ Jr, Delaney KM, Moorman, AC et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
13. Gea-Banacloche JC, Clifford Lane H. Immune reconstitution in HIV infection. AIDS 1999;13(Suppl A):25-38.
14. + lymphocyte percent: a useful immunological marker for monitoring HIV-1 infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:158-62.
15. + T cells levels: results of 6 years follow up. J Acquir Immune Defic Syndr Hum Retrovirol 1993; 6:904-12.
16. + cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:83-92.
17. Finkel TH, Tudor-Williams G, Banda NK, et al. Apoptosis occurs predominantly in bystender cells and not in productive cells of HIV- and SIV-infected lymph nodes. Nature Med 1995;1:129-34.
18. Chen JJ, Huang JC, Shirtliff M, et al. CD4 lymphocytes in the blood of HIV(+) individuals migrate rapidly to lymph nodes and bone marrow: support for homing theory of CD4 cell depletion. J Leukoc Biol 2002;72:271-8.
19. Gougeon ML. Apotosis as an HIV strategy to escape immune atack. Nat Rev Immunol 2003;3:392-404.
20. + T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env. J Virol 2002;76:5082-93.
21. Schnizlein-Bick CT, Mandy FF, O'Gorman MR, et al. Use of CD45 gating in three and four-color flow cytometric immunophenotyping: guideline from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 2002;50:46-52.